Emerson’s Majority Owned Subsidiary, AspenTech, Announces Agreement To Acquire Metals And Mining Software Leader Micromine
Acquisition will further AspenTech’s diversification into metals and mining market through end-to-end software provider
ST. LOUIS--(BUSINESS WIRE)-- Emerson’s (NYSE:EMR) majority owned subsidiary, AspenTech
USA Wholesale Inventories (MoM) for Jun 1.900% vs 1.800% Prior
USA Wholesale Inventories (MoM) for Jun 1.900% vs 1.800% prior reading.
Randolph Bancorp Q2 EPS $0.12 Down From $0.34 YoY
Randolph Bancorp (NASDAQ:RNDB) reported quarterly earnings of $0.12 per share. This is a 64.71 percent decrease over earnings of $0.34 per share from the same period last year.
Bluejay Diagnostics Highlights PResentatin At AACC 2022
Demonstrated 98% NPV1 to Identify COVID-19 Patients at Risk for Severe Illness
Study Data Indicate Symphony IL-6 Test Could be a Rapid and Precise Diagnostic Platform for Near-Patient Management of Critical
Soligenix Receives Agreement From FDA On Initial Pediatric Study Plan For HyBryte For The Treatment Of Cutaneous T-Cell Lymphoma
Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced
Rollins Q2 EPS $0.20, Inline, Sales $714.00M Beat $686.33M Estimate
Rollins (NYSE:ROL) reported quarterly earnings of $0.20 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $714.00 million which
ObsEva Announces Restructuring Including Termination Of Linzagolix License Agreement With Kissei And Company Resizing
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
GENEVA, Switzerland – July 27, 2022 – ObsEva SA (NASDAQ:OBSV, SIX: OBSN)))), a biopharmaceutical company developing novel